Crossmark

Prospective study on the potential of RAAS blockade to halt renal disease in Alport syndrome patients with heterozygous mutations

Crossref DOI link: https://doi.org/10.1007/s00467-016-3452-z

Published Online: 2016-07-11

Published Print: 2017-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Stock, Johanna

Kuenanz, Johannes

Glonke, Niklas

Sonntag, Joseph

Frese, Jenny

Tönshoff, Burkhard

Höcker, Britta

Hoppe, Bernd

Feldkötter, Markus

Pape, Lars

Lerch, Christian

Wygoda, Simone

Weber, Manfred

Müller, Gerhard-Anton

Gross, Oliver
License Information

License valid from 2016-07-11